Abstract
One of the main goals of radiopharmaceutical chemistry is the development of compounds that can be used for the identification or erradication of specific cell populations. Since monoclonal antibodies (MAbs) can be generated, at least in principle, against almost any cellular determinant, there has been a great deal of interest in using MAbs as a mechanism for targeting radionuclides. Although diagnostic and therapeutic investigations with labeled MAbs have focused on their applications in the management of cancer, labeled MAbs also may be useful in the noninvasive diagnosis of infections and heart disease. Numerous problems must be solved before radiolabeled MAbs can make a meaningful impact on the clinical domain, including the development of better MAb labeling methods than those that have been utilized in clinical studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaij, C., Tschrotts, W.R.J.M., Lendner, L., and Feltkamp, T.E.W., 1975, The preparation of astatine labeled proteins, Int. J. Appl. Radiat. Isot. 26:25.
Barendsen, G.W., Koot, C.J., van Kersen, G.R., Bewley, D.K., Field, S.B., and Parnell, C.J., 1966, The effect of oxygen on the impairment of the proliferative capacity of human cells in culture by ionizing radiations of different LET, Int. J. Radiat. Biol. 10:317.
Bolton, A.E. and Hunter, W.M., 1973, The labelling of proteins to high specific activities by conjugation to a I-125 containing acylating agent, Biochem. J. 133:529.
Bolton, A.E. Lee-Own, V., McLean, R.K., and Challand, G.S., 1979, Three different radioiodination methods for human spleen ferritin compared, Clin. Chem. 25:1826.
Delaloye, B., Bischof-Delaloye, A., Buchegger, F., von Fliedner, V., Grob, J.-P., Volant, J.-C., Pettavel, J., and Mach, J.-P., 1986, Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab’)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies, J. Clin. Invest. 77:301.
Dumas, P., Maziere, B., Autissier, N., and Michel, R., 1973, Specificite de l’iodotyrosine desiodase des microsomes thyroidiens et hepatiques, Biochim. Biophys. Acta 293:36.
Fraker, P.J., and Speck, J.C., 1978, Protein and cell membrane iodinations with a sparingly soluble chloramide 1, 3, 4, 6-tetrachloro-3∝ −6∝-diphenylglycouril, Biochem. Biophys. Res. Comm., 80:849.
Friedman, A.M., Zalutsky, M.R., Wung, W., Buckingham, F., Harper, P.V., Sherr, G.H. Wainer, B., Hunter, R.L., Appelman, E.H., Rothberg, R.M., Fitch, F.W., Stuart, F.P., and Simonian, S.J., 1977, Preparation of a biologically stable and immunogenically competent astatinated protein, Int. J. Nucl. Med. Biol. 4:219.
Garg, P.K, Slade, S.K., Harrison, C.L., and Zalutsky, M.R., 1989a, Labeling proteins using aryl iodide acylation agents: Influence of meta vs para substitution on in vivo stability, Nucl. Med. Biol., 16:669.
Garg, P.K., Archer, Jr., G.E., Bigner, D.D., and Zalutsky, M.R., 1989b, Synthesis of radioiodinated N-succinimidyl iodobenzoate: Optimization for use in antibody labelling, Appl. Radiat. Isot., 40:485.
Garg, P.K., Harrison, C.L., and Zalutsky, M.R., 1990, Comparative tissue distribution in mice of the ∝-emitter 211At and 131 I as labels of a monoclonal antibody and F(ab’)2 fragment, Cancer Res, 50:3514.
Garg, S., Garg, P.K., and Zalutsky, M.R., 1991a, N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: A new class of reagents for protein radioiodination, Bioconiugate Chem., 2:50.
Garg, P.K., Garg, S., and Zalutsky, M.R., 1991b, Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity, Bioconjugate Chem., 2:44.
Gershengorn, M.C., Glinoer, D., and Robbins, J., 1980, Transport and metabolism of thyroid hormones, In: “The Thyroid Gland”, 81, M. DeVisscher, ed., Raven Press, New York.
Harrison, A. and Royle, L., 1984, Preparation of a At-211-IgG conjugate which is stable in vivo, Int. J. Appl. Radiat. Isot. 35:1005.
Hayes, D.F., Zalutsky, M.R., Kaplan, W., Noska, M., Thor, A., Colcher, D. and Kufe, D.W., 1986, Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer, Cancer Res. 46:3157.
Hayes, D.F., Noska, M.A., Kufe, D.W., and Zalutsky, M.R., 1988, Effect of radioiodination on the binding of monoclonal antibody DF3 to breast carcinoma cells, Nucl. Med. Biol., 15:235.
Hnatowich, D.J., Virzi, F., and Doherty, P.W., 1985, DTPA-coupled antibodies labelled with yitrium-90, J. Nucl. Med. 26:503.
Hunter, W.M., and Greenwood, F.C., 1962, Preparation of iodine-131 labelled human growth hormone of high specific activity, Nature 194:495.
Kilbourn, M.R., Dence, C.S., Welch, M.J., and Mathias, C.J., 1987, Fluorine-18 labeling of proteins, J. Nucl. Med. 28:462.
Koehrle, J., Auf’mkolk, M., Rokos, H., Hesch, R.D., and Cody, V., 1986, Rat liver iodothyronine ligand-binding site, J. Biol. Chem. 261:11613.
Larson, S.M., and Carrasquillo, J.A., 1988, Advantages of radioiodine over radioindium labeled monoclonal antibodies for imaging solid tumors, Nucl. Med. Biol. 15:231.
Leonard, J.L., and Rosenbert, I.N., 1977, Subcellular distribution of thyroxine 5′p-deiodinase in the rat kidney: A plasma membrane location, Endocrinology 103:274.
Marchalonis, J.J., 1969, An enzymatic method for the trace iodination of immunoglobulins and other proteins, Biochem. J. 113:299.
Narula, A.S. and Zalutsky, M.R., 1988, Synthesis of N-succinimidyl-2, 4-dimethoxy-3-(tri-n-butylstannyl)benzoate via regio-specifically generated lithium 2, 4-dimethoxy-3-lithiobenzoate, Tetrahedron Lett. 29:4385.
Narula, A.S., and Zalutsky, M.R., 1989, No-carrier-added astatination of N-succinimidyl-3-(tri-n-butylstannyl)benzoate (ATE) via electrophilic destannylation, Radiochimica Acta, 47:131.
Pressman, D., Day, E.D., and Blau, M., 1957, The use of paired labeling in the determination of tumor-localizing antibodies, Cancer Res., 17:845.
Shechter, Y., Burstein, Y., and Patchornik, A., 1975, Selective oxidation of methionine residues in proteins, Biochem., 14:4497.
Smallridge, R.C., Burman, K.D., Ward, K.E., Wartofsky, L., Dimond, R.C., Wright, F.D., and Latham, K.R., 1981, 3′5-Diiodothyronine to 3′-monoiodothhyronine conversion in the fed and fasted rat: Enzyme characteristics and evidence for two distinct 5′-deiodinases, Endocrinology 108:2336.
Stanbury, J.B., and Morris, M.L., 1958, Deiodination of diiodotyrosine by cell-free systems, J. Biol. Chem., 233:106.
Sullivan, D.C., Silva, J.S., Cox, C.E., Haagensen, Jr, D.E., Harris, C.C., Briner, W.H., and Wells, Jr., S.A., 1982, Localization of I-131 labeled goat and primate anticarcinoembryonic antigen (CEA) antibodies in patients with cancer, Invest. Radiol., 17:350.
Vaidyanathan, G., and Zalutsky, M.R., 1990a, Radioiodination of antibodies via N-succinimidyl 2, 4-dimethoxy-3-(tri-alkylstannyl)benzoates, Bioconiugate Chem., 1:387.
Vaidyanathan, G., and Zalutsky, M.R., 1990b, Protein radiohalogenation: Observations on the design of N-succinimidyl ester acylation agents, Bioconjuqate Chem., 1:269.
Vaughan, A.T.M. and Fremlin, J.H., 1978, The preparation of astatine labeled proteins using an electrophilic reaction, Int. J. Nucl., Med. Biol. 5:229.
Visser, G.W.M., Diemer, E.L., and Kaspersen, F.M., 1979, The preparation and stability of astatotyrosine and astatoiodotyrosine, Int. J. Appl. Radiat. Isot. 30:749.
Wilbur, D.S., Hadley, S.W., Hylarides, M.D., Abrams, P.G., Beaumier, P.A., Morgan, A.C., Reno, J.M., and Fritzberg, A.R., 1989, Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer, J. Nucl. Med. 30:216.
Wursthorn, K.R., Kuivila, H.G., and Smith, G.F., 1978, Nucleophilic aromatic substitution by organostannylsodiums. A second-order reaction displaying a solvent cage effect, J. Am. Chem. Soc. 100:2779.
Zalutsky, M.R., Colcher, D., Kaplan, W., and Kufe, D.F., 1985, Radioiodinated B6.2 monoclonal antibody: Further characterization of a potential radicpharmaceutical for the identification of breast tumors, Int. J. Nucl. Med. Biol., 12:227.
Zalutsky, M.R. and Narula, A.S., 1987, A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine, Appl. Radiat. Isot. 38:1051.
Zalutsky, M.R. and Narula, A.S., 1988a, Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate, Cancer Res., 48:1446.
Zalutsky, M.R., and Narula, A.S., 1988b, Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate, Appl. Radiat. Isot., 3:227.
Zalutsky, M.R., Noska, M.A., Colapinto, E.V., Garg, P.K., and Bigner, D.D., 1989a, Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate, Cancer Res., 49:5543.
Zalutsky, M.R., Garg, P.K., Friedman, H.S., and Bigner, D.D., 1989b, Labeling monoclonal antibodies and F (ab′) 2 fragments with the ∝-particle-emitting nuclide astatine-211: Preservation of immunoreactivity and in vivo localizing capacity, Proc. Natl. Acad. Sci. (USA), 86:7149.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zalutsky, M.R., Garg, P.K., Vaidyanathan, G., Garg, S. (1991). Methods for the Radiohalogenation of Antibodies. In: Kelly, J.W., Baldwin, T.O. (eds) Applications of Enzyme Biotechnology. Industry-University Cooperative Chemistry Program Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9235-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9235-5_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9237-9
Online ISBN: 978-1-4757-9235-5
eBook Packages: Springer Book Archive